Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic, Congenital

Explore clinical trials studying Anemia, Hemolytic, Congenital. Study availability and eligibility vary by location and protocol.

1,131 public trials 184 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic, Congenital trial results

Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, Not Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

NCT05356195

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • TriStar Medical Group Children's Specialists - Pediatric Oncology Nashville, Tennessee, United States
  • Hospital for Sick Children - Hematology Toronto, Canada
  • University Hospital Dusseldorf - Department of Pediatric Oncology, Hematology and Clinical Immunology Düsseldorf, Germany
  • IRCSS Ospedale Pediatrico Bambino Gesu - Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica Rome, Italy
View Trial Details
Active, Not Recruiting

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

NCT06421636

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Weill Cornell Medicine New York, United States
  • K Eristavi National Center of Experimental and Clinical Surgery Tbilisi, Georgia
  • Medinvest Institute of Hematology and Transfusiology Limited Tbilisi, Georgia
  • Children's Hospital Agia Sophia Athens, Attica, Greece
View all 26 locations
View Trial Details
Active, Not Recruiting

Realizing Effectiveness Across Continents With Hydroxyurea (REACH)

NCT01966731

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Hospital Pediátrico David Bernardino Luanda, Angola
  • Centre Hospitalier Monkole Kinshasa, Democratic Republic of the Congo
  • KEMRI/Wellcome Trust Research Kilifi, Kenya
  • Ministry of Health Mbale Regional Hospital Mbale, Uganda
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

NCT05031780

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCLA Health Los Angeles, California, United States
  • Children's Hospital Oakland Oakland, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

NCT04084080

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama Tuscaloosa, Alabama, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Howard University Center for Sickle Cell Disease Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

NCT06924970

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • UCHealth at University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • UConn Health Farmington, Connecticut, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 30 locations
View Trial Details

Related conditions